GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (BOM:512529) » Definitions » Cyclically Adjusted PB Ratio

Sequent Scientific (BOM:512529) Cyclically Adjusted PB Ratio : 4.53 (As of Jan. 18, 2025)


View and export this data going back to 1991. Start your Free Trial

What is Sequent Scientific Cyclically Adjusted PB Ratio?

As of today (2025-01-18), Sequent Scientific's current share price is ₹173.20. Sequent Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was ₹38.22. Sequent Scientific's Cyclically Adjusted PB Ratio for today is 4.53.

The historical rank and industry rank for Sequent Scientific's Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:512529' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.06   Med: 3.23   Max: 5.63
Current: 4.66

During the past years, Sequent Scientific's highest Cyclically Adjusted PB Ratio was 5.63. The lowest was 2.06. And the median was 3.23.

BOM:512529's Cyclically Adjusted PB Ratio is ranked worse than
79.42% of 656 companies
in the Drug Manufacturers industry
Industry Median: 2.11 vs BOM:512529: 4.66

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sequent Scientific's adjusted book value per share data for the three months ended in Sep. 2024 was ₹27.274. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹38.22 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sequent Scientific Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sequent Scientific's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequent Scientific Cyclically Adjusted PB Ratio Chart

Sequent Scientific Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 4.13 2.09 3.15

Sequent Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.63 - 3.15 - 6.08

Competitive Comparison of Sequent Scientific's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sequent Scientific's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sequent Scientific's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sequent Scientific's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sequent Scientific's Cyclically Adjusted PB Ratio falls into.



Sequent Scientific Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sequent Scientific's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=173.20/38.22
=4.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sequent Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Sequent Scientific's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book=Book Value per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=27.274/157.8822*157.8822
=27.274

Current CPI (Sep. 2024) = 157.8822.

Sequent Scientific Quarterly Data

Book Value per Share CPI Adj_Book
201412 0.000 96.780 0.000
201503 9.320 97.163 15.144
201506 0.000 99.841 0.000
201509 32.230 101.753 50.009
201512 0.000 102.901 0.000
201603 39.696 102.518 61.133
201606 0.000 105.961 0.000
201609 38.589 105.961 57.498
201612 0.000 105.196 0.000
201703 40.076 105.196 60.148
201706 0.000 107.109 0.000
201709 38.644 109.021 55.963
201712 0.000 109.404 0.000
201803 26.569 109.786 38.208
201806 0.000 111.317 0.000
201809 25.658 115.142 35.182
201812 0.000 115.142 0.000
201903 28.626 118.202 38.236
201906 0.000 120.880 0.000
201909 27.859 123.175 35.709
201912 0.000 126.235 0.000
202003 27.664 124.705 35.024
202006 0.000 127.000 0.000
202009 30.127 130.118 36.555
202012 0.000 130.889 0.000
202103 29.297 131.771 35.103
202106 0.000 134.084 0.000
202109 30.633 135.847 35.602
202112 0.000 138.161 0.000
202203 27.747 138.822 31.557
202206 0.000 142.347 0.000
202209 29.569 144.661 32.271
202212 0.000 145.763 0.000
202303 28.015 146.865 30.117
202306 0.000 150.280 0.000
202309 25.324 151.492 26.392
202312 0.000 152.924 0.000
202403 26.366 153.035 27.201
202406 0.000 155.789 0.000
202409 27.274 157.882 27.274

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sequent Scientific  (BOM:512529) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sequent Scientific Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sequent Scientific's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequent Scientific Business Description

Traded in Other Exchanges
Address
Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Sequent Scientific Headlines

No Headlines